Katrina L. Houde's most recent trade in Lifecore Biomedical Inc was a trade of 19,506 Common Stock done . Disclosure was reported to the exchange on July 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lifecore Biomedical Inc | Katrina L. Houde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2025 | 19,506 | 109,412 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | Katrina L. Houde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2024 | 30,000 | 89,906 (0%) | 0% | - | Common Stock | |
| Sunopta, Inc. | Katrina L. Houde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 20,072 | 20,072 | - | - | Restricted Stock Units | |
| Sunopta, Inc. | Katrina L. Houde | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2024 | 15,283 | 216,869 (0%) | 0% | - | Common Shares | |
| Sunopta, Inc. | Katrina L. Houde | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2024 | 15,283 | 0 | - | - | Restricted Stock Units | |
| Lifecore Biomedical Inc | L. Houde Katrina | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 9,554 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | L. Houde Katrina | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 9,554 | 59,906 (0%) | 0% | - | Common Stock | |
| Sunopta, Inc. | Katrina L. Houde | Director | Sale of securities on an exchange or to another person at price $ 4.40 per share. | 21 Aug 2023 | 45,000 | 201,586 (0%) | 0% | 4.4 | 198,063 | Common Shares |
| Sunopta, Inc. | Katrina L. Houde | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 14,018 | 246,586 (0%) | 0% | - | Common Shares | |
| Sunopta, Inc. | Katrina L. Houde | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 14,018 | 0 | - | - | Restricted Stock Units | |
| Lifecore Biomedical Inc | Katrina L. Houde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 18,182 | 50,352 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | Katrina L. Houde | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 9,474 | 32,170 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | Katrina L. Houde | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 9,474 | 0 | - | - | Restricted Stock Unit | |
| Sunopta, Inc. | Katrina L. Houde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2023 | 15,283 | 15,283 | - | - | Restricted Stock Units | |
| Sunopta, Inc. | Katrina L. Houde | Director | Grant, award, or other acquisition of securities at price $ 8.21 per share. | 02 Feb 2023 | 1,700 | 232,568 (0%) | 0% | 8.2 | 13,957 | Common Shares |
| Lifecore Biomedical Inc | Katrina L. Houde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 9,554 | 9,554 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Katrina L. Houde | Director | Grant, award, or other acquisition of securities at price $ 9.50 per share. | 04 Jun 2022 | 7,059 | 22,696 (0%) | 0% | 9.5 | 67,061 | Common Stock |
| Lifecore Biomedical Inc | Katrina L. Houde | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2022 | 7,059 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Katrina L. Houde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 9,474 | 9,474 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Katrina L. Houde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 7,059 | 7,059 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Katrina L. Houde | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 8,303 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Katrina L. Houde | Director | Grant, award, or other acquisition of securities at price $ 11.64 per share. | 01 Jun 2021 | 8,303 | 15,637 (0%) | 0% | 11.6 | 96,647 | Common Stock |
| Lifecore Biomedical Inc | Katrina L. Houde | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2020 | 7,334 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Katrina L. Houde | Director | Grant, award, or other acquisition of securities at price $ 10.36 per share. | 15 Oct 2020 | 7,334 | 7,334 (0%) | 0% | 10.4 | 75,980 | Common Stock |